BPC-157 (Body Protection Compound-157) has become one of the most discussed peptides in the biohacking community. Originally isolated from human gastric juice, this 15-amino-acid peptide has demonstrated remarkable healing properties in preclinical research. Here's what the science actually says.
What Is BPC-157?
BPC-157 is a synthetic peptide derived from a protein found naturally in human stomach acid. It belongs to a class of compounds called body protection compounds, which play a role in the body's natural healing and regenerative processes. The peptide has been studied extensively in animal models for its effects on wound healing, tendon and ligament repair, gut healing, and neuroprotection.
What Does the Research Show?
The majority of BPC-157 research has been conducted in animal models, with promising results across multiple systems. Studies have shown accelerated healing of muscle, tendon, and ligament injuries, protection against NSAID-induced gut damage, improved blood vessel formation (angiogenesis), neuroprotective effects, and anti-inflammatory properties. A 2024 systematic review of BPC-157 research in sports medicine found consistent evidence for tissue repair acceleration, though the authors noted the critical need for human clinical trials.
Common Protocols
While no official human dosing guidelines exist (BPC-157 is not FDA-approved), the biohacking community has converged on several common protocols. Typical reported dosages range from 250-500mcg per day, administered either subcutaneously near the injury site or orally in capsule form. Cycles typically last 4-12 weeks. The oral form has gained popularity with the availability of stable oral BPC capsules, though subcutaneous injection remains the most commonly discussed route in online communities.
Safety Considerations
BPC-157 has shown a favorable safety profile in animal studies, with no reported toxic effects even at high doses. However, several important caveats apply: human clinical trial data is extremely limited, long-term effects are unknown, peptide quality varies dramatically between suppliers, and regulatory status is uncertain. The FDA has not approved BPC-157 for any medical use, and it is classified as a research chemical.
The Bottom Line
BPC-157 shows genuine promise based on preclinical research, but we must be honest about the limitations of the current evidence base. If you're considering BPC-157, consult with a healthcare provider familiar with peptide therapy, source only from reputable, third-party tested suppliers, start with the lowest commonly reported dose, and monitor your body's response carefully.
Disclaimer: BPC-157 is not FDA-approved for human use. This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before using any peptide.